Sarbjit S Saini

6PUBLICATIONS
23CO-AUTHORS
AllergyGene and molecular therapyPharmacogenomicsCatalysis and mechanisms of reactions
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 09, 2026
Management of chronic urticaria: Current status and future prospect.

|Jun 02, 2025
Efficacy and safety of CT-P39, an omalizumab biosimilar, in chronic spontaneous urticaria: 16-week follow-up study.

|Nov 26, 2022
Pharmacokinetic equivalence of CT-P39 and reference omalizumab in healthy individuals: A randomised, double-blind, parallel-group, Phase 1 trial.

Marcus Maurer, Sarbjit S Saini, Kristi McLendon

|Aug 25, 2021
Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial.

Jonathan Corren, Sarbjit S Saini, Remi Gagnon

|Jun 08, 2019
Emerging Therapies in Chronic Spontaneous Urticaria.

Taek Ki Min, Sarbjit S Saini

Pageof 1

Frequent Collaborators

2 joint publications

Clive Grattan

2 joint publications

Marcus Maurer

1 joint publications

Andaç Salman

1 joint publications

Mona Al-Ahmad